Aimmune is located in Brisbane, California - the heart of San Francisco’s biotechnology hub - with additional offices in Durham, North Carolina; the Paddington area of London, England; Dublin, Ireland; and Munich, Germany.
Location: United States, California, Brisbane
Employees: 201-500
Phone: +1 650-614-5220
Total raised: $145M
Founded date: 2011
Investors 6
| Date | Name | Website |
| - | SWK Holdin... | swkhold.co... |
| - | Aisling Ca... | aislingcap... |
| - | Foresite C... | foresiteca... |
| - | RA Capital... | racap.com |
| - | Vivo Capit... | vivocapita... |
| - | Longitude ... | longitudec... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.11.2016 | - | $145M | - |
Mentions in press and media 17
| Date | Title | Description | Source |
| 03.03.2022 | Egg allergy trials halted by Aimmune; Atlas closes its 13th ... | A Phase II trial for Aimmune’s drug to treat children and young adults with egg allergies has been t... | endpts.com... |
| 23.09.2020 | Healthcare VC Firm Longitude Capital Closes $585M Fund | What You Should Know: – Healthcare venture capital firm Longitude Capital announces the close of it... | hitconsult... |
| 23.09.2020 | Longitude Capital Raises $585 Million Fund to Invest in Tran... | - Longitude Venture Partners IV will build on the Firm’s commitment to improve clinical outcomes, en... | marketscre... |
| 31.08.2020 | Aimmune Therapeutics soars 172% after Nestle agrees to acqui... | Aimmune Therapeutics soared 172% on Monday after Nestle Health Science agreed to acquire the company... | businessin... |
| 05.02.2020 | Nestlé puts $200M more behind a treatment for peanut alle... | Aimmune’s patients won’t ever be able to eat much or even most of their candy, but every time the... | endpts.com... |
| 13.09.2019 | FDA expert panel gives thumbs-up to Aimmune’s peanut allergy... | A panel of experts convened by the Food and Drug Administration voted in support of the agency appro... | medcitynew... |
| 20.06.2019 | Assessing the value of new food allergy treatments must incl... | Walk into any classroom in America today and you’ll likely find at least two children with a food al... | statnews.c... |
| 12.11.2018 | Nestlé ups its bet on Aimmune’s peanut allergy drug to $2... | Nestlé Health Science is upping its bet on Aimmune Therapeutics by $98 million $AIMT, with it... | endpts.com... |
| 05.05.2018 | A life sciences firm run by a top VC and a cofounder of Alph... | There’s no end to the number of fascinating devices and therapies being created right now in the fie... | techcrunch... |
| 22.02.2018 | Evelo Bio raises $47.5M for I/O work; Vertex gets started... | → Seven months after Google-backed Evelo Biosciences brought its total venture raise to $100 mi... | endpts.com... |
Show more